2023 Department of Pediatrics Academic Annual Report

GRANTS AWARDED IN 2023 (continued)

INVESTIGATOR PROJECT TITLE

SPONSOR

DIRECT AWARDED

Hashizume, Rintaro

Intranasal Delivery of Targeting Nanoliposomal Therapeutics for Pediatric Glioma

Pediatric Cancer Research Foundation

$90,724

Hashizume, Rintaro

Targeting Transcriptional Elongation in Pediatric Glioma

National Institute of Neurological Disorders and Stroke/NIH/DHHS

$254,642

Johnston, Emily Elizabeth

Quality of End-of-Life Care for Children with Cancer: Can We Measure It Across Diverse Populations

American Cancer Society, Inc.

$135,000

Kasztan, Malgorzata

The Role of Endothelin-1 in Renal Iron Handling in Sickle Cell Disease

American Society of Nephrology

$90,910

Kasztan, Malgorzata

The Role of Endothelin-1 iIn Tubular Injury iIn Sickle Cell Disease

National Heart, Lung, and Blood Institute/NIH/DHHS

$167,677

Landier, Wendy

Implementation of a Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors Rreceiving Follow-Up Care in Pediatric Oncology Practices: A Cluster-Randomized Trial

National Cancer Institute/NIH/ DHHS

$512,621

Lebensburger, Jeffrey David

The Association Between Food Insecurity and CKD in Patients with SCA

American Society of Hematology

$50,000

Lebensburger, Jeffrey David

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

National Heart, Lung, and Blood Institute/NIH/DHHS

$134,700

Lebensburger, Jeffrey David

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

National Heart, Lung, and Blood Institute/NIH/DHHS

$858,001

Metrock, Laura Katherine

LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Day One Biopharmaceuticals

$72,510

Metrock, Laura Katherine

Clinical Trial Award— - Selumentinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Young Children with Neurofibromatosis Type 1 (NF1)

DOD - Department of Defense

$97,529

2023 Academic Annual Report

83